Skip to main content
Clinical Trials/CTRI/2019/10/021622
CTRI/2019/10/021622
Recruiting
N/A

Keyar foetal heart rate and uterine contraction monitoring device in the detection of foetal distress during intra-partum period

Janitri Innovations Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: O76- Abnormality in fetal heart rate and rhythm complicating labor and deliveryHealth Condition 2: O998- Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
Sponsor
Janitri Innovations Pvt Ltd
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Janitri Innovations Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Pregnant woman \> 18 years of age
  • 2\. Gestational age between 37\+0 to 40\+6 weeks
  • 3\. Cephalic presentation in labour
  • 4\. Both low and high risk pregnancies
  • 5\. Ability to understand study information and willing to provide written informed consent

Exclusion Criteria

  • 1\. Multiple pregnancy
  • 2\. Congenital anomalies of the foetus
  • 3\. Patient admitted with false labour pain
  • 4\. Patient undergoing elective caesarean sections
  • 5\. Any other condition of the mother or foetus where in, the investigator feels the participant is not eligible for the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
N/A
The study of the measurement of fetal heart rate by using ultrasonography.pregnant women
JPRN-UMIN000016592Kawasaki Medical School50
Not Yet Recruiting
N/A
A study to determine the comparability between the Paxxy monitor compared to CTG and pulse oximetry in monitoring fetal and maternal heart rates among term mothers with uncomplicated singleton pregnancy – single arm study
SLCTR/2024/026Paxxy FMS LLC30
Not Yet Recruiting
N/A
Role of fetal cardiac function at term pregnancy in the prediction of neonatal outcomeHealth Condition 1: O779- Labor and delivery complicated byfetal stress, unspecified
CTRI/2021/02/031388Dr Akhila Vasudeva
Recruiting
N/A
Monitoring and diagnosing fetal cardiac (ar)rhythmias per CTG-registration and fetal ECG by the Monica AN24tm.congenital heart arrhythmias1000751010016849
NL-OMON34791eids Universitair Medisch Centrum200
Active, Not Recruiting
N/A
Maternal, uteroplacental and fetal haemodynamic effect of Nicardipine in severe pre-eclampsia. - CORCA IIHypertensive crisis in patients with severe pre-eclampsia needs to be treated to prevent maternal and fetal complications. The maternal, uteroplacental and fetal haemodynamic respose to antihypertensive treatment with Nicardipinehydrochloride will be evaluated in detail by materal echocardiography and fetal doppler ultrasound as well as by the effect on plasma Brain Natriuretic Peptide concentration (BNP) and parameters of the Renin- Angiotensin- Aldosterone system (RAAS).MedDRA version: 9.1Level: LLTClassification code 10040445Term: Severe pre-eclampsia, antepartumMedDRA version: 9.1Level: LLTClassification code 10053094Term: Doppler echocardiographyMedDRA version: 9.1Level: LLTClassification code 10045412Term: Ultrasound DopplerMedDRA version: 9.1Level: LLTClassification code 10058179Term: Hypertensive emergencyMedDRA version: 9.1Level: LLTClassification code 10038555Term: ReninMedDRA version: 9.1Level: LLTClassification code 10002491Term: Angiotensin IIMedDRA version: 9.1Level: LLTClassification code 10053406Term: Brain natriuretic peptideMedDRA version: 9.1Level: LLTClassification code 10001644Term: Aldosterone
EUCTR2007-000727-17-NLErasmus MC10